ArticleInternational journal of oncology2017

SERP1 is a novel marker of poor prognosis in pancreatic ductal adenocarcinoma patients via anti-apoptosis and regulating SRPRB/NF-κB axis.

Qiang Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.